UCL School of Management

Simcha Jong

Visiting Professor


Simcha is a Visiting Professor at the UCL School of Management, and a full Professor and Director of Science Based Business at Leiden University in the Netherlands. Simcha previously held faculty appointments at the Harvard T.H. Chan School of Public Health (visiting), and at the UCL School of Management where he was the faculty chair of the UCL Healthcare Management Initiative.

Simcha’s research group studies innovation processes in science-based industries, and the changing dynamics governing academic work. Simcha received funding from major UK and international funding bodies such as the ERC, Innovate UK, ESRC, NESTA, NIHR, and BIS, as well as various industry partners for projects examining business development strategies for science-based firms, and the commercialisation of disruptive cell therapy and personalised medicine technologies.

Simcha has a PhD in Social and Political Sciences from the European University Institute in Florence, Italy, an MPhil in Management Studies from the University of Cambridge (first class honours with distinction level), and a BA in Social Science from Utrecht University’s University College (cum laude). In addition, he was a visiting scholar at the Department of Sociology at UC Berkeley.

Simcha’s research has been published in leading international scientific and management journals, including Nature Biotechnology, Research Policy, Industrial and Corporate Change, and Journal of Management Studies. Simcha was elected Honorary Cambridge University European Trust Scholar, awarded the first prize in the PRIME Early Career Competition, a DIME WP European Framework Grant for qualitative research on university entrepreneurship, a Georgia Tech Science and Technology policy conference early career prize, and an Academy of Management OB Most Innovative Student paper award.

PhD and Postdoctoral researchers from Simcha’s group moved on to academic positions in management and science policy at  top-institutions such as UCL, Warwick Business School, Indian Institute of Technology, Georgia Tech, National Taiwan University, SPRU, University of Chicago, Middlesex University, and Bristol University. 


Simcha’s research focuses on the intersection of policy, R&D, and healthcare. His projects examine challenges involved in building successful science-based ventures, in implementing disruptive technological innovations in healthcare settings, and in organising scientific work in an academic landscape that is increasingly internationally interconnected and tied into industrial R&D. The latter topic is the focus of a five-year ERC consolidator grant project Simcha is leading. In his research, Simcha builds on theory in the sociology, technology management, and entrepreneurship literature. 
Research projects

Managing R&D in science-based industries

Corporate R&D organizations and their relationships with academic laboratories

Cell therapy

Decision support tools for cell therapy commercialisation and business development

Personalised medicine

Assessing and implementing new diagnostics strategies for stratifying patients

Universities as engines of technological change

An examination of academic organisations at the forefront of the biotechnology revolution
Selected publications
Huang, H., & Jong, S. (2019). Public Funding for Science and the Value of Corporate R&D Projects; Evidence from Project Initiation and Termination Decisions in Cell Therapy. JOURNAL OF MANAGEMENT STUDIES, 56 (5), 1000-1039. doi:10.1111/joms.12423 [link]
Atun, R., Davies, J. I., Gale, E. A. M., Barnighausen, T., Beran, D., Kengne, A. P., . . . Werfalli, M. (2017). Diabetes in sub-Saharan Africa: from clinical care to health policy. LANCET DIABETES & ENDOCRINOLOGY, 5 (8), 622-667. doi:10.1016/S2213-8587(17)30181-X [link]
Wong, S. C. K., Sasportas, L. S., Richardson, K., Gordon, B. R., Jayatunga, M. K. P., Shalizi, A., . . . Perez, D. A. (2015). Keys to the kingdom. NATURE BIOTECHNOLOGY, 33 (3), 232-236. doi:10.1038/nbt.3159 [link]
Jong, S., & Slavova, K. (2014). When publications lead to products: The open science conundrum in new product development. Research Policy, 43 (4), 645-654. doi:10.1016/j.respol.2013.12.009 [link]
JONG, S. (2011). Commercializing a disruptive technology. Nature Biotechnology, 29 (8), 685-688. doi:10.1038/bioe.2011.6 [link]

Link to the publication’s UCL Discovery page